Navigation Links
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Date:10/29/2009

safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

    Table 1
                              Amicus Therapeutics, Inc.
                            (a development stage company)
                        Consolidated Statements of Operations
                                    (Unaudited)
                 (In thousands, except share and per share amounts)

                                                                 Period from
                                                                  February
                            Three Months         Nine Months       4, 2002
                               Ended                Ended      (inception) to
                            September 30,        September 30,   September 30,
                            -------------        ------------   -------------
                           2008       2009       2008      2009       2009
                           ----       ----       ----      ----       ----
    Revenue:
      Research revenue   $2,959     $4,219     $8,539    $12,799     $26,362
      Collaboration
       revenue              694        694      2,083      2,083       5,270
                            ---        ---      -----      -----       -----
    Total revenue         3,653      4,913     10,622     14,882      31,632
                          -----      -----     ------     ------      ------

    Operating Expenses:
      Research and
       development        8,200     12,609     23,989     37,954     165,596
      General and
       administrative     4,371      5,217     14,676     15,635      73,371
      Impairment of
       leasehold
       improvements           -          -          -          -       1,030
      Depreciation and
       amortization         382        561      1,036      1,585       5,872
      In-process research
       and development        -          -          -          -         418
                           
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015 /CNW/ - Portage Biotech Inc. ("Portage" ... PBT.U), is pleased to announce that its wholly owned ... research study that showed one of its proprietary human-derived ... brain tissue through inhibition of NFkB signalling even if ... The permeability of the blood brain barrier (BBB) in ...
(Date:4/20/2015)... --  Meditope Biosciences, Inc ., a biotechnology company developing ... presentation of data demonstrating the use of its SnAP ... data were presented in an abstract at the AACR ... Philadelphia . "We are ... many commercial applications that may be possible for our ...
(Date:4/20/2015)... Whitehouse Laboratories is pleased and overly excited to ... and Drug Administration (FDA) inspection and received no observations ... compliance inspection, as based upon 21CFR Parts 210 and ... and was granted NAI (no action indicated) status. The ... Manufacturing Practice (GMP) quality system required by the regulatory ...
(Date:4/17/2015)... 17, 2015  Centrillion Technologies, a genomic ... from the National Human Genome Research Institute, ... (NIH). The grant will help fund the ... of breakthrough genomic technologies, including phased sequencing ... Centrillion has been developing this transformative and ...
Breaking Biology Technology:Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
(Date:3/18/2015)... March 18, 2015 As mobile payments ... revolutionary smart wallets and apps continue to be introduced into ... in the mobile payment industry in focus today are:  NXT-ID, ... (NYSE: BABA ), Apple Inc. (NASDAQ: ... Facebook Inc. (NASDAQ: FB ) NXT-ID, ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... As a result of field work by associate professor James ... of the Ryukyus in Okinawa, Japan has found two ... in unexpected locations. The species belong to the genus ... species in the Indian Ocean. Surprisingly, the new species were ...
... articles about the Deepwater Horizon oil spill provides ... science used in the unprecedented response effort by ... behind-the-scenes look at the extensive scientific and engineering ... outside the governmentassembled to respond to the disaster. ...
... Calif., Nov. 29, 2012  Medbox, Inc. (OTC Markets: MDBX) ... their unique and patented biometric medical marijuana dispensing system ... recent days. The Medbox system provides patients with safe, ... products in states that have legal medical marijuana programs. ...
Cached Biology News:An ocean away: 2 new encrusting anemones found in unexpected locations 2Research, response for future oil spills: Lessons learned from Deepwater Horizon 2Research, response for future oil spills: Lessons learned from Deepwater Horizon 3Research, response for future oil spills: Lessons learned from Deepwater Horizon 4Medbox, Inc. Featured in Multiple Media Stories in Massachusetts and California 2Medbox, Inc. Featured in Multiple Media Stories in Massachusetts and California 3